[Immunogenic properties of the toxic constituents of Shigella dysenteriae type 1].
D000818:Animals; D003231:Conjunctivitis / Q000517:prevention & control*; D004405:Dysentery, Bacillary / Q000517:prevention & control*; D004731:Endotoxins / Q000494:pharmacology / Q000627:therapeutic use; D006168:Guinea Pigs; D007114:Immunization; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051379:Mice; D012621:Seasons; D012762:Shigella dysenteriae / Q000276:immunology*; D014118:Toxins, Biological / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use
D004731:Endotoxins; D014118:Toxins, Biological
Propriétés immunogènes des compsants tociques de Shigella dysenteriae type 1.